_id
69105634ccc777a4e85d5611
Ticker
CSWYY
Name
China Shineway Pharmaceutical Group Ltd ADR
Exchange
PINK
Address
No. 168, Shiluan Street, Shijiazhuang, China, 051430
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
https://www.shineway.com
Description
China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People's Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; tablets, pills, oral liquid, and powder; and traditional Chinese medicine granules in various therapeutic areas, including respiratory system disease, nervous system, digestive system disease, cardiovascular and cerebrovascular, orthopedics, pediatrics, and other areas, as well as medication for strengthening the body. It is also involved in the trading of agricultural products. The company was incorporated in 2002 and is headquartered in Shijiazhuang, China. China Shineway Pharmaceutical Group Limited is a subsidiary of Forway Investment Limited.
Last Close
22.08
Volume
1
Current Price
19.25
Change
0
Last Updated
2026-01-02T12:07:16.620Z
Image
-
Ipo Date
-
Market Cap
754476160
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.997
Sentiment Sources
1
Current Quarter
2025-06-30
Revenue
227809215
Cost Of Revenue
63281608
Gross Profit
164527606
Operating Expenses
113419684
Operating Income
51107922
Interest Expense
808298
Pretax Income
106782235
Net Income
84725640
Eps
44.86398729150119
Dividends Per Share
37484978
Shares Outstanding
37770000
Income Tax Expense
22056595
EBITDA
117781795
Operating Margin
22.43452794479802
Total Other Income Expense Net
55674313
Cash
6860819000
Short Term Investments
100419000
Receivables
1269312000
Inventories
722369000
Total Current Assets
8952919000
Property Plant Equipment
1225148000
Total Assets
10387656000
Payables
377676000
Short Term Debt
308512000
Long Term Debt
28477000
Total Liabilities
2578033000
Equity
7809623000
Bs_currency_symbol
CNY
Depreciation
10191259
Change In Working Capital
-
Cash From Operations
95284796
Capital Expenditures
13868716
Cash From Investing
39166774
Cash From Financing
-38279630
Net Change In Cash
116277472
Cf_currency_symbol
-
PE
6.2298
PB
0.004654978223660732
ROE
1.0848877084079473
ROA
0.8156377146104954
FCF
81416080
Fcf Percent
0.3573871232557471
Piotroski FScore
4
Health Score
63
Deep Value Investing Score
10
Defensive Investing Score
7
Dividend Investing Score
3.5
Economic Moat Investing Score
9.8
Garp Investing Score
6.5
Growth Investing Score
5
Momentum Investing Score
8
Net Net Investing Score
8
Quality Investing Score
8.5
Value Investing Score
8.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
227809215
Quarters > 0 > income Statement > cost Of Revenue
63281608
Quarters > 0 > income Statement > gross Profit
164527606
Quarters > 0 > income Statement > operating Expenses
113419684
Quarters > 0 > income Statement > operating Income
51107922
Quarters > 0 > income Statement > interest Expense
808298
Quarters > 0 > income Statement > pretax Income
106782235
Quarters > 0 > income Statement > net Income
84725640
Quarters > 0 > income Statement > eps
44.86398729150119
Quarters > 0 > income Statement > dividends Per Share
37484978
Quarters > 0 > income Statement > shares Outstanding
1888500
Quarters > 0 > income Statement > income Tax Expense
22056595
Quarters > 0 > income Statement > EBITDA
117781795
Quarters > 0 > income Statement > operating Margin
22.43452794479802
Quarters > 0 > income Statement > total Other Income Expense Net
55674313
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
6860819000
Quarters > 0 > balance Sheet > short Term Investments
100419000
Quarters > 0 > balance Sheet > receivables
1269312000
Quarters > 0 > balance Sheet > inventories
722369000
Quarters > 0 > balance Sheet > total Current Assets
8952919000
Quarters > 0 > balance Sheet > property Plant Equipment
1225148000
Quarters > 0 > balance Sheet > total Assets
10387656000
Quarters > 0 > balance Sheet > payables
377676000
Quarters > 0 > balance Sheet > short Term Debt
308512000
Quarters > 0 > balance Sheet > long Term Debt
28477000
Quarters > 0 > balance Sheet > total Liabilities
2578033000
Quarters > 0 > balance Sheet > equity
7809623000
Quarters > 0 > balance Sheet > currency_symbol
CNY
Quarters > 0 > cash Flow > net Income
84725640
Quarters > 0 > cash Flow > depreciation
10191259
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
95284796
Quarters > 0 > cash Flow > capital Expenditures
13868716
Quarters > 0 > cash Flow > cash From Investing
39166774
Quarters > 0 > cash Flow > cash From Financing
-38279630
Quarters > 0 > cash Flow > net Change In Cash
116277472
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
44.86398729150119
Quarters > 0 > ratios > PB
0.004654978223660732
Quarters > 0 > ratios > ROE
1.0848877084079473
Quarters > 0 > ratios > ROA
0.8156377146104954
Quarters > 0 > ratios > FCF
81416080
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.3573871232557471
Quarters > 0 > health Score
63
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
235617617
Quarters > 1 > income Statement > cost Of Revenue
60150650
Quarters > 1 > income Statement > gross Profit
175466967
Quarters > 1 > income Statement > operating Expenses
137099009
Quarters > 1 > income Statement > operating Income
38367957
Quarters > 1 > income Statement > interest Expense
456510
Quarters > 1 > income Statement > pretax Income
39512926
Quarters > 1 > income Statement > net Income
29752340
Quarters > 1 > income Statement > eps
15.754482393433943
Quarters > 1 > income Statement > dividends Per Share
11809863
Quarters > 1 > income Statement > shares Outstanding
1888500
Quarters > 1 > income Statement > income Tax Expense
9760586
Quarters > 1 > income Statement > EBITDA
50210081
Quarters > 1 > income Statement > operating Margin
16.28399331447275
Quarters > 1 > income Statement > total Other Income Expense Net
1144969
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
6140153000
Quarters > 1 > balance Sheet > short Term Investments
350020000
Quarters > 1 > balance Sheet > receivables
1201877000
Quarters > 1 > balance Sheet > inventories
813190000
Quarters > 1 > balance Sheet > total Current Assets
8598523000
Quarters > 1 > balance Sheet > property Plant Equipment
1219402000
Quarters > 1 > balance Sheet > total Assets
10041530000
Quarters > 1 > balance Sheet > payables
402964000
Quarters > 1 > balance Sheet > short Term Debt
338271000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
2574626000
Quarters > 1 > balance Sheet > equity
7466904000
Quarters > 1 > balance Sheet > currency_symbol
CNY
Quarters > 1 > cash Flow > net Income
29752340
Quarters > 1 > cash Flow > depreciation
10240640
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
62234270
Quarters > 1 > cash Flow > capital Expenditures
9194250
Quarters > 1 > cash Flow > cash From Investing
-55656667
Quarters > 1 > cash Flow > cash From Financing
-12379179
Quarters > 1 > cash Flow > net Change In Cash
-16896333
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
15.754482393433943
Quarters > 1 > ratios > PB
0.004868634309480878
Quarters > 1 > ratios > ROE
0.3984561740716099
Quarters > 1 > ratios > ROA
0.2962928956045543
Quarters > 1 > ratios > FCF
53040020
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.22511058670116335
Quarters > 1 > health Score
66
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
289187720
Quarters > 2 > income Statement > cost Of Revenue
71304269
Quarters > 2 > income Statement > gross Profit
217883451
Quarters > 2 > income Statement > operating Expenses
140195887
Quarters > 2 > income Statement > operating Income
77687560
Quarters > 2 > income Statement > interest Expense
395248
Quarters > 2 > income Statement > pretax Income
119473050
Quarters > 2 > income Statement > net Income
86821521
Quarters > 2 > income Statement > eps
2.2986899920571884
Quarters > 2 > income Statement > dividends Per Share
45015938
Quarters > 2 > income Statement > shares Outstanding
37770000
Quarters > 2 > income Statement > income Tax Expense
32651529
Quarters > 2 > income Statement > EBITDA
131049179
Quarters > 2 > income Statement > operating Margin
26.864059096285274
Quarters > 2 > income Statement > total Other Income Expense Net
41785490
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
6234974000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
1399788000
Quarters > 2 > balance Sheet > inventories
830292000
Quarters > 2 > balance Sheet > total Current Assets
8465054000
Quarters > 2 > balance Sheet > property Plant Equipment
1213205000
Quarters > 2 > balance Sheet > total Assets
9884356000
Quarters > 2 > balance Sheet > payables
460685000
Quarters > 2 > balance Sheet > short Term Debt
338679000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
2547931000
Quarters > 2 > balance Sheet > equity
7336425000
Quarters > 2 > balance Sheet > currency_symbol
CNY
Quarters > 2 > cash Flow > net Income
86821521
Quarters > 2 > cash Flow > depreciation
11180880
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
95334888
Quarters > 2 > cash Flow > capital Expenditures
10324418
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-41421975
Quarters > 2 > cash Flow > net Change In Cash
27779516
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
2.2986899920571884
Quarters > 2 > ratios > PB
0.09910446845704823
Quarters > 2 > ratios > ROE
1.1834309081057872
Quarters > 2 > ratios > ROA
0.878373067501818
Quarters > 2 > ratios > FCF
85010470
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.293962931759343
Quarters > 2 > health Score
70
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
2117858000
Quarters > 3 > income Statement > cost Of Revenue
527696000
Quarters > 3 > income Statement > gross Profit
1590162000
Quarters > 3 > income Statement > operating Expenses
1067535000
Quarters > 3 > income Statement > operating Income
384090000
Quarters > 3 > income Statement > interest Expense
354527
Quarters > 3 > income Statement > pretax Income
568965000
Quarters > 3 > income Statement > net Income
478045000
Quarters > 3 > income Statement > eps
253.1347630394493
Quarters > 3 > income Statement > dividends Per Share
83094000
Quarters > 3 > income Statement > shares Outstanding
1888500
Quarters > 3 > income Statement > income Tax Expense
90920000
Quarters > 3 > income Statement > EBITDA
463874000
Quarters > 3 > income Statement > operating Margin
18.13577680845458
Quarters > 3 > income Statement > total Other Income Expense Net
184875000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
5888776000
Quarters > 3 > balance Sheet > short Term Investments
20000000
Quarters > 3 > balance Sheet > receivables
1260367000
Quarters > 3 > balance Sheet > inventories
897709000
Quarters > 3 > balance Sheet > total Current Assets
8154730000
Quarters > 3 > balance Sheet > property Plant Equipment
1205287000
Quarters > 3 > balance Sheet > total Assets
9573993000
Quarters > 3 > balance Sheet > payables
484791000
Quarters > 3 > balance Sheet > short Term Debt
300971000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
2539225000
Quarters > 3 > balance Sheet > equity
7034768000
Quarters > 3 > balance Sheet > currency_symbol
CNY
Quarters > 3 > cash Flow > net Income
478045000
Quarters > 3 > cash Flow > depreciation
91000000
Quarters > 3 > cash Flow > change In Working Capital
-168104000
Quarters > 3 > cash Flow > cash From Operations
611254000
Quarters > 3 > cash Flow > capital Expenditures
95176000
Quarters > 3 > cash Flow > cash From Investing
3653000
Quarters > 3 > cash Flow > cash From Financing
-89218000
Quarters > 3 > cash Flow > net Change In Cash
-5364576000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
253.1347630394493
Quarters > 3 > ratios > PB
0.005167707733929534
Quarters > 3 > ratios > ROE
6.795462195768219
Quarters > 3 > ratios > ROA
4.993162205153064
Quarters > 3 > ratios > FCF
516078000
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.24367922684145962
Quarters > 3 > health Score
65
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
3778043000
Annuals > 0 > income Statement > cost Of Revenue
946294000
Annuals > 0 > income Statement > gross Profit
2831749000
Annuals > 0 > income Statement > operating Expenses
1989147000
Annuals > 0 > income Statement > operating Income
842602000
Annuals > 0 > income Statement > interest Expense
6129000
Annuals > 0 > income Statement > pretax Income
1145721000
Annuals > 0 > income Statement > net Income
840052000
Annuals > 0 > income Statement > eps
444.8249933809902
Annuals > 0 > income Statement > dividends Per Share
407916000
Annuals > 0 > income Statement > shares Outstanding
1888500
Annuals > 0 > income Statement > income Tax Expense
305669000
Annuals > 0 > income Statement > EBITDA
1220585000
Annuals > 0 > income Statement > operating Margin
22.302604814185546
Annuals > 0 > income Statement > total Other Income Expense Net
303119000
Annuals > 0 > income Statement > currency_symbol
CNY
Annuals > 0 > balance Sheet > cash
6140153000
Annuals > 0 > balance Sheet > short Term Investments
350020000
Annuals > 0 > balance Sheet > receivables
1201877000
Annuals > 0 > balance Sheet > inventories
813190000
Annuals > 0 > balance Sheet > total Current Assets
8598523000
Annuals > 0 > balance Sheet > property Plant Equipment
1219402000
Annuals > 0 > balance Sheet > total Assets
10041530000
Annuals > 0 > balance Sheet > payables
402964000
Annuals > 0 > balance Sheet > short Term Debt
338271000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
2574626000
Annuals > 0 > balance Sheet > equity
7466904000
Annuals > 0 > balance Sheet > currency_symbol
CNY
Annuals > 0 > cash Flow > net Income
1145721000
Annuals > 0 > cash Flow > depreciation
68735000
Annuals > 0 > cash Flow > change In Working Capital
221959000
Annuals > 0 > cash Flow > cash From Operations
963135000
Annuals > 0 > cash Flow > capital Expenditures
140112000
Annuals > 0 > cash Flow > cash From Investing
-272110000
Annuals > 0 > cash Flow > cash From Financing
-392475000
Annuals > 0 > cash Flow > net Change In Cash
251377000
Annuals > 0 > cash Flow > currency_symbol
CNY
Annuals > 0 > ratios > PE
444.8249933809902
Annuals > 0 > ratios > PB
0.004868634309480878
Annuals > 0 > ratios > ROE
11.250338828515808
Annuals > 0 > ratios > ROA
8.365776928416286
Annuals > 0 > ratios > FCF
823023000
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
0.21784373550009886
Annuals > 0 > health Score
72
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
4516538000
Annuals > 1 > income Statement > cost Of Revenue
1122419000
Annuals > 1 > income Statement > gross Profit
3394119000
Annuals > 1 > income Statement > operating Expenses
2418584000
Annuals > 1 > income Statement > operating Income
975535000
Annuals > 1 > income Statement > interest Expense
2737000
Annuals > 1 > income Statement > pretax Income
1240253000
Annuals > 1 > income Statement > net Income
969510000
Annuals > 1 > income Statement > eps
513.3756949960286
Annuals > 1 > income Statement > dividends Per Share
317268000
Annuals > 1 > income Statement > shares Outstanding
1888500
Annuals > 1 > income Statement > income Tax Expense
270743000
Annuals > 1 > income Statement > EBITDA
1420092000
Annuals > 1 > income Statement > operating Margin
21.599176183173928
Annuals > 1 > income Statement > total Other Income Expense Net
264718000
Annuals > 1 > income Statement > currency_symbol
CNY
Annuals > 1 > balance Sheet > cash
5888776000
Annuals > 1 > balance Sheet > short Term Investments
20000000
Annuals > 1 > balance Sheet > receivables
1260367000
Annuals > 1 > balance Sheet > inventories
897709000
Annuals > 1 > balance Sheet > total Current Assets
8154730000
Annuals > 1 > balance Sheet > property Plant Equipment
1205287000
Annuals > 1 > balance Sheet > total Assets
9573993000
Annuals > 1 > balance Sheet > payables
484791000
Annuals > 1 > balance Sheet > short Term Debt
300971000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
2539225000
Annuals > 1 > balance Sheet > equity
7034768000
Annuals > 1 > balance Sheet > currency_symbol
CNY
Annuals > 1 > cash Flow > net Income
1240253000
Annuals > 1 > cash Flow > depreciation
177102000
Annuals > 1 > cash Flow > change In Working Capital
-93616000
Annuals > 1 > cash Flow > cash From Operations
932635000
Annuals > 1 > cash Flow > capital Expenditures
144325000
Annuals > 1 > cash Flow > cash From Investing
-49540000
Annuals > 1 > cash Flow > cash From Financing
-26738000
Annuals > 1 > cash Flow > net Change In Cash
862511000
Annuals > 1 > cash Flow > currency_symbol
CNY
Annuals > 1 > ratios > PE
513.3756949960286
Annuals > 1 > ratios > PB
0.005167707733929534
Annuals > 1 > ratios > ROE
13.781691165934685
Annuals > 1 > ratios > ROA
10.12649581005543
Annuals > 1 > ratios > FCF
788310000
Annuals > 1 > ratios > Piotroski FScore
3
Annuals > 1 > ratios > fcf Percent
0.17453855143032118
Annuals > 1 > health Score
72
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
3950636000
Annuals > 2 > income Statement > cost Of Revenue
1012322000
Annuals > 2 > income Statement > gross Profit
2938314000
Annuals > 2 > income Statement > operating Expenses
2119758000
Annuals > 2 > income Statement > operating Income
713576000
Annuals > 2 > income Statement > interest Expense
630000
Annuals > 2 > income Statement > pretax Income
917025000
Annuals > 2 > income Statement > net Income
722773000
Annuals > 2 > income Statement > eps
382.72332539052155
Annuals > 2 > income Statement > dividends Per Share
241728000
Annuals > 2 > income Statement > shares Outstanding
1888500
Annuals > 2 > income Statement > income Tax Expense
194252000
Annuals > 2 > income Statement > EBITDA
1103517000
Annuals > 2 > income Statement > operating Margin
18.06230692982092
Annuals > 2 > income Statement > total Other Income Expense Net
203449000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
5026265000
Annuals > 2 > balance Sheet > short Term Investments
3693000
Annuals > 2 > balance Sheet > receivables
975062000
Annuals > 2 > balance Sheet > inventories
657659000
Annuals > 2 > balance Sheet > total Current Assets
6782399000
Annuals > 2 > balance Sheet > property Plant Equipment
1216937000
Annuals > 2 > balance Sheet > total Assets
8231861000
Annuals > 2 > balance Sheet > payables
308745000
Annuals > 2 > balance Sheet > short Term Debt
6530000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
1849335000
Annuals > 2 > balance Sheet > equity
6382526000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
722773000
Annuals > 2 > cash Flow > depreciation
185862000
Annuals > 2 > cash Flow > change In Working Capital
-228410000
Annuals > 2 > cash Flow > cash From Operations
1109676000
Annuals > 2 > cash Flow > capital Expenditures
129463000
Annuals > 2 > cash Flow > cash From Investing
-45420000
Annuals > 2 > cash Flow > cash From Financing
-250038000
Annuals > 2 > cash Flow > net Change In Cash
820543000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
382.72332539052155
Annuals > 2 > ratios > PB
0.005695805234479264
Annuals > 2 > ratios > ROE
11.324246857748797
Annuals > 2 > ratios > ROA
8.780189558594346
Annuals > 2 > ratios > FCF
980213000
Annuals > 2 > ratios > Piotroski FScore
3
Annuals > 2 > ratios > fcf Percent
0.24811524017904965
Annuals > 2 > health Score
71
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
3223550000
Annuals > 3 > income Statement > cost Of Revenue
813214000
Annuals > 3 > income Statement > gross Profit
2410336000
Annuals > 3 > income Statement > operating Expenses
1793118000
Annuals > 3 > income Statement > operating Income
534365000
Annuals > 3 > income Statement > interest Expense
1254000
Annuals > 3 > income Statement > pretax Income
720103000
Annuals > 3 > income Statement > net Income
556674000
Annuals > 3 > income Statement > eps
294.8716318863979
Annuals > 3 > income Statement > dividends Per Share
453072000
Annuals > 3 > income Statement > shares Outstanding
1887852
Annuals > 3 > income Statement > income Tax Expense
163429000
Annuals > 3 > income Statement > EBITDA
903743000
Annuals > 3 > income Statement > operating Margin
16.576910548928975
Annuals > 3 > income Statement > total Other Income Expense Net
185738000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
4205722000
Annuals > 3 > balance Sheet > short Term Investments
4323000
Annuals > 3 > balance Sheet > receivables
-4323000
Annuals > 3 > balance Sheet > inventories
587956000
Annuals > 3 > balance Sheet > total Current Assets
5699112000
Annuals > 3 > balance Sheet > property Plant Equipment
1251999000
Annuals > 3 > balance Sheet > total Assets
7203958000
Annuals > 3 > balance Sheet > payables
228620000
Annuals > 3 > balance Sheet > short Term Debt
7587000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
1302477000
Annuals > 3 > balance Sheet > equity
5901481000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
556674000
Annuals > 3 > cash Flow > depreciation
182386000
Annuals > 3 > cash Flow > change In Working Capital
-207098000
Annuals > 3 > cash Flow > cash From Operations
703150000
Annuals > 3 > cash Flow > capital Expenditures
93633000
Annuals > 3 > cash Flow > cash From Investing
395011000
Annuals > 3 > cash Flow > cash From Financing
-828935000
Annuals > 3 > cash Flow > net Change In Cash
262712000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
294.8716318863979
Annuals > 3 > ratios > PB
0.006157971363459443
Annuals > 3 > ratios > ROE
9.432784753522041
Annuals > 3 > ratios > ROA
7.727335445320476
Annuals > 3 > ratios > FCF
609517000
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
0.18908253323199578
Annuals > 3 > health Score
69
Valuation > metrics > PE
6.2298
Valuation > metrics > PB
0.004654978223660732
Valuation > final Score
90
Valuation > verdict
68.6% Undervalued
Profitability > metrics > ROE
1.0848877084079473
Profitability > metrics > ROA
0.9463465490975626
Profitability > metrics > Net Margin
0.3719148937851351
Profitability > final Score
35
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.330109788910425
Risk > metrics > Interest Coverage
63.229059084644526
Risk > final Score
100
Risk > verdict
Low
Liquidity > metrics > Current Ratio
13.047326680151794
Liquidity > metrics > Quick Ratio
11.994599147755425
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
100
Prev Valuations > 1
90
Prev Valuations > 2
40
Prev Profitabilities > 0
21
Prev Profitabilities > 1
35
Prev Profitabilities > 2
61
Prev Risks > 0
100
Prev Risks > 1
100
Prev Risks > 2
100
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:40:07.612Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-26
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-27
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0.81
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-04-24
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0.28
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
0.28
Earnings History > 2 > surprise Percent
-
China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People's Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; tablets, pills, oral liquid, and powder; and traditional Chinese medicine granules in various therapeutic areas, including respiratory system disease, nervous system, digestive system disease, cardiovascular and cerebrovascular, orthopedics, pediatrics, and other areas, as well as medication for strengthening the body. It is also involved in the trading of agricultural products. The company was incorporated in 2002 and is headquartered in Shijiazhuang, China. China Shineway Pharmaceutical Group Limited is a subsidiary of Forway Investment Limited.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-06-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of China Shineway Pharmaceutical Group Ltd ADR
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
2025-06-30
EPS Actual
0.81
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.